CONMED names John Gallagher as CFO, effective July 2026

CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.

Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.

Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.

He previously spent nine years at Becton, Dickinson & Co., where he held several roles including Corporate Treasurer, Controller/Chief Accounting Officer, and Senior Vice President and CFO of BD's Medical Segment. Earlier in his career, he held finance roles at General Electric Company and Ford Motor Company.

Gallagher holds an MBA from the University of Pittsburgh and a B.S. in Finance from Clemson University.

"John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations," said Patrick J. Beyer, CONMED's President and Chief Executive Officer.

CONMED makes devices and equipment for surgical procedures used across specialties including orthopedics, general surgery, gynecology, and thoracic surgery.

You May Also Be Interested In

• CVR Energy names new CEO after predecessor's resignation
• Loop Industries adds GVIC chairman to board amid planned stake increase
• Lilly's $7.8 billion acquisition of Centessa cleared by English court